|
REL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.484800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.470300E-02 |
| Normal-vs-Stage2 |
5.083600E-01 |
| Normal-vs-Stage3 |
5.68039999999659E-05 |
| Normal-vs-Stage4 |
3.033400E-04 |
| Stage1-vs-Stage2 |
6.452000E-01 |
| Stage1-vs-Stage3 |
1.935760E-03 |
| Stage1-vs-Stage4 |
1.276470E-02 |
| Stage2-vs-Stage3 |
1.074820E-01 |
| Stage2-vs-Stage4 |
1.167000E-01 |
| Stage3-vs-Stage4 |
9.507200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.524800E-03 |
| Normal-vs-AfricanAmerican |
1.002500E-02 |
| Normal-vs-Asian |
6.464000E-01 |
| Caucasian-vs-AfricanAmerican |
5.626200E-01 |
| Caucasian-vs-Asian |
5.696600E-01 |
| AfricanAmerican-vs-Asian |
4.299200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.614000E-04 |
| Normal-vs-Female |
6.451600E-02 |
| Male-vs-Female |
1.026990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.756500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.636600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.354030E-02 |
| Normal-vs-Age(81-100Yrs) |
9.897700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.351200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.813800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.793600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.073000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.454000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.446600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.514000E-01 |
| Normal-vs-Grade 2 |
1.871820E-02 |
| Normal-vs-Grade 3 |
3.935700E-03 |
| Normal-vs-Grade 4 |
4.232900E-04 |
| Grade 1-vs-Grade 2 |
6.581600E-02 |
| Grade 1-vs-Grade 3 |
5.156200E-02 |
| Grade 1-vs-Grade 4 |
1.022020E-02 |
| Grade 2-vs-Grade 3 |
1.636800E-01 |
| Grade 2-vs-Grade 4 |
2.413500E-02 |
| Grade 3-vs-Grade 4 |
3.380200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.316160E-01 |
| Normal-vs-ccB subtype |
2.124700E-03 |
| ccA subtype-vs-ccB subtype |
8.320200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.342900E-03 |
| Normal-vs-N1 |
2.454200E-01 |
| N0-vs-N1 |
8.778200E-01 |
|
|
